CYSTARAN Drug Patent Profile
✉ Email this page to a colleague
▶ Start for $1
Remove trial restrictions
Which patents cover Cystaran, and when can generic versions of Cystaran launch?
Cystaran is a drug marketed by Leadiant Biosci Inc and is included in one NDA.
The generic ingredient in CYSTARAN is cysteamine hydrochloride. There are six drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the cysteamine hydrochloride profile page.
Summary for CYSTARAN
| US Patents: | 0 |
| Applicants: | 1 |
| NDAs: | 1 |
| Finished Product Suppliers / Packagers: | 1 |
| Raw Ingredient (Bulk) Api Vendors: | 102 |
| Patent Applications: | 3,301 |
| Formulation / Manufacturing: | see details |
| Drug Prices: | Drug price information for CYSTARAN |
| What excipients (inactive ingredients) are in CYSTARAN? | CYSTARAN excipients list |
| DailyMed Link: | CYSTARAN at DailyMed |
Pharmacology for CYSTARAN
| Drug Class | Cystine Depleting Agent |
| Mechanism of Action | Cystine Disulfide Reduction |
US Patents and Regulatory Information for CYSTARAN
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Leadiant Biosci Inc | CYSTARAN | cysteamine hydrochloride | SOLUTION/DROPS;OPHTHALMIC | 200740-001 | Oct 2, 2012 | RX | Yes | Yes | ⤷ Try a Trial | ⤷ Try a Trial | ⤷ Try a Trial | ||||
| >Applicant | >Tradename | >Generic Name | >Dosage | >NDA | >Approval Date | >TE | >Type | >RLD | >RS | >Patent No. | >Patent Expiration | >Product | >Substance | >Delist Req. | >Exclusivity Expiration |
